why do pbms limit glp-1 medications 📢 CMS Announces Medicare Bridge Demonstration Program The Centers for Medicare & Medicaid Services (CMS) has released new guidance on the Medicare GLP-1 Bridge, a short-term demonstration program running July 1 –December How Traditional PBMs Use GLP-1s

Remember, consulting with a qualified healthcare professional is key to harnessing the full potential of glutathione

Novo Nordisk continues to face legal and financial repercussions as concerns grow over whether the drug causes serious, life-changing side effects

After Novos oral version of Wegovy was approved, the company chose to work with other health platforms and left Hims out

cognition-orientated clinical trials: people with risk or diagnosed AD In a clinical trial in individuals at risk of AD, participants aged 45 to 70 years who did not have diabetes or a history of neurological disorders were recruited

Accessed January 25, 2026

Gastrodia elata Blume (tianma) mobilizes neuro-protective capacities in Parkinsons